TY  - GEN
AU  - Lambert,J S
AU  - McNamara,J
AU  - Katz,S L
AU  - Fenton,T
AU  - Kang,M
AU  - VanCott,T C
AU  - Livingston,R
AU  - Hawkins,E
AU  - Moye,J
AU  - Borkowsky,W
AU  - Johnson,D
AU  - Yogev,R
AU  - Duliege,A M
AU  - Francis,D
AU  - Gershon,A
AU  - Wara,D
AU  - Martin,N
AU  - Levin,M
AU  - McSherry,G
AU  - Smith,G
TI  - Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218)
SN  - 1077-9450
PY  - 1998///1231
KW  - AIDS Vaccines
KW  - administration & dosage
KW  - Adolescent
KW  - CD4 Lymphocyte Count
KW  - Child
KW  - Child, Preschool
KW  - Cohort Studies
KW  - Disease Progression
KW  - Double-Blind Method
KW  - Female
KW  - HIV Envelope Protein gp120
KW  - immunology
KW  - HIV Envelope Protein gp160
KW  - HIV Infections
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Immunotherapy, Active
KW  - adverse effects
KW  - Infant
KW  - Injections, Intramuscular
KW  - Lymphocyte Activation
KW  - Male
KW  - Vaccines, Synthetic
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1097/00042560-199812150-00003
ER  -